700 patients110,866 observations180 daysLIVE

Patient P-02377

Synthetic patientMETA-24 · Day 121 · 75+ · M · baseline S19Steering view · 3DOpen companion preview
Therapy response
Improving
Tolerance
Improving
GI state
Improving
Inflammatory state
Improving
Nutritional resilience
Improving
Discontinuation risk
21%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 META-24 startedBaseline state S19
  2. Day 43 Trajectory diverged from predictionObserved response fell below the model's expected path.

What changed?

Trajectory began diverging from predicted response on Day 43.

Primary contributors, last 14 days
  • Treatment adherence-14
  • Toxicity-12
  • Inflammatory activity-11
  • GI instability-9
  • Nutritional resilience+9

What helped?

No interventions yet.

    LIFE OS recommendation
    No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

    Daily trackers

    Molecule settings

    The trackers this program marks as important, last 14 days vs the 14 before.

    Active minutes
    Wearable
    50 min
    worsening · -2.3 vs previous 14 d
    Sleep duration
    Wearable
    7 h
    stable · -0.2 vs previous 14 d
    Energy level
    Daily log
    6.2/10
    worsening · -0.3 vs previous 14 d
    Steps
    Wearable
    6,091
    stable · -190 vs previous 14 d
    GI burden
    Companion
    20.2/100
    worsening · +4.8 vs previous 14 d
    Adherence
    Companion
    77.6 %
    worsening · -8.7 vs previous 14 d
    Sleep quality
    Wearable
    44.4/100
    worsening · -5.1 vs previous 14 d
    Glucose, CGM daily mean
    CGM
    122 mg/dL
    stable · +2.9 vs previous 14 d
    This trajectory is doing well — what to keep, what to watch
    Steering view →

    Heading towards restoration · 73 from the failing basin, 17 from restoration.

    Good elements to keep
    • Butyrate producers intact
      hidden · steering +7.5
    • Protein (supports)
      perturbation · steering +6.5
    • Protein
      supporter · GI -4 next day
    Main detractors to watch
    • Bacteroides fragilis elevated
      hidden · steering -7.4
    • IL6 high-expression variant
      hidden · steering -7.3
    • Ultra-processed food
      perturbation · steering -4.8
    • Poor-sleep week
      perturbation · steering -3
    • Ultra-processed food
      detractor · GI +2.8 next day
    State influencers · digestive

    Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

    • Protein
      -4supporter · 95%
    • Ultra-processed food
      +2.8detractor · 95%
    • Simple carbohydrates
      -1.3no signal · 39%
    • Dietary fat load
      +0.9no signal · 30%
    • Insoluble fibre
      -0.3no signal · 15%
    • Alcohol
      -0.3no signal · 15%
    • Histamine load
      +0.2no signal · 15%
    • Caffeine
      -0.1no signal · 15%

    Biological layers

    Which pathways look influenced, and by which layer of this person's biology.

    Pathways under pressure
    • Inflammatory signalling 45
      • DNAIL6 -174 variant raises baseline inflammatory tone
      • MicrobiomeBacteroides fragilis expansion
    • Mucosal barrier integrity 30
      • MicrobiomeAkkermansia low → thinner mucus layer
    DNA
    Fictional pharmacogenomic panel
    • IL6 -174 G/C
      Higher inflammatory tone
    • CYP2D6 Normal metabolizer
      Expected exposure
    • GLP1R rs6923761 A
      Altered receptor sensitivity
    • MTHFR C677T
      Reduced folate turnover
    Microbiome
    Shannon diversity 4.4 · butyrate capacity 47/100
    • Akkermansia muciniphilaLow
    • Faecalibacterium prausnitziiNormal
    • Bacteroides fragilisHigh
    • Bifidobacterium longumNormal
    • EnterobacteriaceaeNormal
    Wearable, last 14 days
    daily evolution fed into the runtime
    HRV
    48 ms
    Sleep
    6.5 h
    Steps
    5,112
    Resting HR
    65 bpm
    Daily log: GI score 20, nutritional resilience 62, adherence 78.

    What this patient sees in NostraAI

    The content that steers the trajectory: what to eat, what to do, what to take.

    Open companion preview
    What to eat
    • Keep meals regular; three to four moderate portions spaced through the day
    • Include a cooked vegetable portion with each main meal
    • Keep fibre steady; no new sources this week
    • Eat slowly and stop at comfortable fullness — smaller volume, more often
    What to do
    • Log the daily check-in; one line is enough
    • Keep the current walking rhythm
    • Keep the sleep window steady
    • Keep hydration steady: small amounts through the day rather than large volumes at once
    What to take
    • Take the dose at the same time relative to your evening meal
    • No additional supplements this week
    • Fictional demo item: continue vitamin D as before

    284 biologically similar trajectories

    Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

    PatientSimilarityBaselineInterventionOutcomeResponse today
    P-0207152%S1952
    P-0219551%S1159
    P-0242751%S0862
    P-0224350%S1461
    P-0248350%S06BR-03no change64
    P-0265850%S0466
    P-0207349%S1454
    P-0210949%S0466
    P-0214049%S0462
    P-0223849%S1863
    P-0242349%S1065
    P-0243749%S0164